Antigen delivery for cross priming via the emulsion vaccine adjuvants

Vaccine

Volumn 30, Issue 9, 2012, Pages 1560-1571

  Shen, Shan Shan ^a   Yang, Ya Wun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adjuvants; Antigen delivery; Emulsion; Vaccine

Indexed keywords

ALUMINUM HYDROXIDE; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; EMULSION VACCINE ADJUVANT; GLYCOPROTEIN P 15095; IMMUNOLOGICAL ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; LYMPH NODE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSPORT KINETICS; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; CELL DEATH; CELL PROLIFERATION; CROSS-PRIMING; DENDRITIC CELLS; EMULSIONS; FLOW CYTOMETRY; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; T-LYMPHOCYTES; VACCINES;

EID: 84862819027     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.120     Document Type: Article

References (24)

1. Yang Y.W., Wei A.C., Shen S.S. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate - a revisit of the role of the hydrophile-lipophile balance (HLB) value. Vaccine 2005, 23(April (20)):2665-2675.
2. Yang Y.W., Shen S.S. Enhanced antigen delivery via cell death induced by the vaccine adjuvants. Vaccine 2007, 25(November (45)):7763-7772.
3. Flach T.L., Ng G., Hari A., Desrosiers M.D., Zhang P., Ward S.M., et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med 2011, 17(April (4)):479-487.
4. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392(March (6671)):86-89.
5. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998, 188(October (7)):1359-1368.
6. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007, 8(November (11)):1217-1226.
7. Wu C.A., Yang Y.W. Induction of cell death by saponin and antigen delivery. Pharm Res 2004, 21(February (2)):271-277.
8. Yang Y.W., Wu C.A., Morrow W.J. Cell death induced by vaccine adjuvants containing surfactants. Vaccine 2004, 22(March (11-12)):1524-1536.
9. Yang Y.W., Wu C.A., Morrow W.J. The apoptotic and necrotic effects of tomatine adjuvant. Vaccine 2004, 22(June (17-18)):2316-2327.
10. Shastri N., Gonzalez F. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J Immunol 1993, 150(April (7)):2724-2736.
11. Hariharan K., Braslawsky G., Black A., Raychaudhuri S., Hanna N. The induction of cytotoxic T cells and tumor regression by soluble antigen formulation. Cancer Res 1995, 55(August (16)):3486-3489.
12. Moore M.W., Carbone F.R., Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988, 54(September (6)):777-785.
13. Karttunen J., Sanderson S., Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci USA 1992, 89(July (13)):6020-6024.
14. Sanderson S., Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 1994, 6(March (3)):369-376.
15. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176(December (6)):1693-1702.
16. Karttunen J., Shastri N. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci USA 1991, 88(May (9)):3972-3976.
17. Nolan G.P., Fiering S., Nicolas J.F., Herzenberg L.A. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-d-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci USA 1988, 85(April (8)):2603-2607.
18. Yang Y.W., Hsu P.Y. The effect of poly(d,l-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens. Biomaterials 2008, 29(June (16)):2516-2526.
19. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000, 191(February (3)):423-434.
20. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461(September (7261)):282-286.
21. Lauber K., Blumenthal S.G., Waibel M., Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004, 14(May (3)):277-287.
22. Inaba K., Turley S., Yamaide F., Iyoda T., Mahnke K., Inaba M., et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998, 188(December (11)):2163-2173.
23. Fujii S., Liu K., Smith C., Bonito A.J., Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004, 199(June (12)):1607-1618.
24. Storni T., Ruedl C., Renner W.A., Bachmann M.F. Innate immunity together with duration of antigen persistence regulate effector T cell induction. J Immunol 2003, 171(July (2)):795-801.